GHK-Cu Research Overview: Copper Tripeptide in Preclinical Studies

Published: March 2026

GHK-Cu (Copper Tripeptide-1): Research Overview

White Market Peptides offers research-grade GHK-Cu (100 mg) at a 99%+ purity standard, third-party tested for identity and purity. View its Certificate of Analysis (PDF) ↗

Overview

GHK-Cu (Glycyl-L-histidyl-L-lysine copper, CAS 49557-75-7) is an endogenously occurring tripeptide-copper complex first isolated from human plasma albumin by Loren Pickart in 1973. In healthy adults, plasma concentrations of GHK reach approximately 200 ng/mL, with levels declining markedly with age, falling to roughly 80 ng/mL by age 60. This age-dependent decline has made GHK-Cu a subject of sustained scientific interest, as researchers have sought to characterize the biological roles of the peptide in tissue homeostasis and wound repair. The tripeptide is composed of three amino acids (glycine, L-histidine, and L-lysine) in a sequence that confers high-affinity copper(II) chelation, with a binding constant reported in the femtomolar range.

Research across several decades has established GHK-Cu as a pleiotropic signaling molecule capable of influencing gene expression, extracellular matrix remodeling, antioxidant enzyme activity, and growth factor production. Of particular note are analyses of publicly available gene expression databases suggesting that GHK modulates the transcription of thousands of human genes, including loci associated with inflammation, DNA repair, and cellular proteostasis. This breadth of molecular activity has made GHK-Cu one of the more intensively studied copper-binding peptides in the biomedical literature.

The compound exists naturally as a constituent of collagen’s alpha-2(I) chain, from which it may be liberated by matrix metalloproteinases (MMPs) at wound sites, a finding that contextualizes its role as an endogenous tissue-repair signal. Its small molecular size (403.93 g/mol) facilitates tissue penetration, and its low effective concentrations (active in vitro at picomolar to nanomolar range) suggest high receptor sensitivity or direct transcriptional activity. GHK-Cu has been investigated in preclinical models spanning dermal wound healing, lung injury, antioxidant defense, and connective tissue remodeling.

Molecular Profile

Mechanism of Action

GHK-Cu exerts its biological effects primarily through copper(II) chelation and the delivery of bioavailable copper to intracellular enzyme systems. Copper is an essential cofactor for lysyl oxidase (an extracellular enzyme that catalyzes the cross-linking of collagen and elastin fibrils), for cytochrome c oxidase in the mitochondrial electron transport chain, and for superoxide dismutase-1 (SOD1), a principal cytoplasmic antioxidant enzyme. By chelating copper in a stable yet biologically accessible form, GHK-Cu has been investigated as a vehicle for targeted intracellular copper delivery, distinct from free ionic copper, which is cytotoxic at elevated concentrations. The histidine residue in the GHK sequence plays a key structural role, providing two nitrogen donors for equatorial coordination with the Cu(II) center, contributing to the complex’s stability at physiological pH.

At the transcriptional level, analyses of publicly available gene expression databases (including the Broad Institute Connectivity Map) have revealed that GHK-Cu is associated with broad modulation of gene networks. Pickart and Margolina (2018) identified evidence that GHK influences the expression of genes in pathways governing inflammation (including downregulation of NF-κB-associated transcripts), DNA repair, ubiquitin-proteasome function, and growth factor signaling. Upstream regulatory analysis suggested GHK-responsive promoter elements in genes controlled by TGF-β1, SP1, and p53 family members. These transcriptional findings align with earlier in vitro observations that GHK-Cu modulates the production of both collagen and MMP enzymes, molecules whose genes are subject to these same transcriptional regulators.

A third mechanistic axis involves antioxidant and anti-inflammatory signaling. In vitro and rodent studies have examined GHK-Cu’s capacity to reduce reactive oxygen species (ROS), attenuate lipopolysaccharide-induced cytokine release (TNF-α, IL-6), and enhance endogenous antioxidant enzyme activity. By maintaining copper in a chelated, catalytically constrained state, GHK-Cu may reduce the pro-oxidant activity of free copper while simultaneously delivering it to copper-dependent enzymes. This dual redox-modulatory role (pro-antioxidant in enzyme delivery, anti-oxidant in free-radical limitation) has been a consistent theme across the mechanistic literature.

Key Areas of Investigation

Collagen and Extracellular Matrix Synthesis

Among the earliest and most replicated findings in the GHK-Cu literature is its stimulatory effect on collagen synthesis in fibroblast cultures. Maquart et al. (1988) demonstrated that GHK-Cu significantly increased type I collagen production in cultured dermal fibroblasts at concentrations as low as 10⁻¹² M, with peak stimulation at 10⁻⁹ M, effects that were independent of changes in cell proliferation rate. The authors proposed that GHK, encoded within the alpha-2(I) chain of type I collagen, may represent an autocrine wound-repair signal released upon collagen proteolysis. Subsequent studies by Wegrowski et al. (1992) further characterized GHK-Cu’s stimulatory effects on the synthesis of sulfated glycosaminoglycans, components of the proteoglycan matrix that contribute to tissue hydration and structural integrity.

GHK-Cu has also been investigated for its effects on matrix metalloproteinase (MMP) biology. Siméon et al. (2000) reported that GHK-Cu increased MMP-2 (gelatinase A) expression in dermal fibroblast cultures while simultaneously elevating levels of TIMP-1 and TIMP-2, endogenous MMP inhibitors, suggesting that the peptide may regulate a coordinated remodeling response rather than simply upregulating protease activity in an uncontrolled manner.

Antioxidant Activity and Redox Modulation

GHK-Cu’s antioxidant properties have been examined through multiple mechanistic lenses. Miller et al. (1990) investigated the effects of GHK-Cu on ferritin-dependent lipid peroxidation, finding that the chelated copper complex attenuated peroxidation in a concentration-dependent manner, attributed to the copper complex’s capacity to interfere with free-radical chain reactions. Park et al. (2016) examined GHK-Cu in a murine model of LPS-induced acute lung injury, reporting that administration was associated with reduced ROS production, increased superoxide dismutase activity, and decreased concentrations of TNF-α and IL-6 in bronchoalveolar lavage fluid. The authors characterized the mechanism as involving suppression of NF-κB p65 and p38 MAPK phosphorylation.

Gene Expression Modulation and Systems Biology

Pickart and Margolina’s 2018 review in the International Journal of Molecular Sciences (PMID 29986520) synthesized gene expression data to map GHK-responsive pathways at the systems level, documenting GHK-associated modulation of gene sets involved in DNA damage response, proteasome-mediated protein degradation, mitochondrial function, and suppression of NF-κB-driven inflammatory transcription. The 2015 review by Pickart, Vasquez-Soltero, and Margolina (PMID 26236730) reported evidence that GHK influences the expression of over 4,000 human genes across multiple tissue contexts, placing it among the more genomically active small peptides studied in the biomedical literature. These bioinformatic findings remain subject to ongoing experimental validation.

Wound Healing and Tissue Repair Models

GHK-Cu has been investigated in numerous preclinical wound-healing models. Siméon et al. (1999) characterized MMP expression patterns in rat wound chambers following GHK-Cu administration, finding modulation of the gelatinase axis consistent with enhanced late-phase remodeling. Pickart’s 2008 review summarized evidence across multiple tissue types (skin, bone, stomach, and liver) where GHK-Cu administration in animal models has been associated with accelerated structural repair, increased VEGF and FGF-2 expression, and recruitment of macrophages and mast cells to wound sites.

Neurological and Cognitive Research Contexts

The age-dependent decline in plasma GHK concentrations has prompted researchers to examine whether the peptide may be relevant to neurological aging. Pickart, Vasquez-Soltero, and Margolina (2012) reviewed evidence in Oxidative Medicine and Cellular Longevity (PMID 22666519) connecting disrupted copper homeostasis, oxidative stress, and neuroinflammation to age-related conditions, and summarized preclinical evidence that GHK influences gene expression programs associated with synaptic plasticity and neurotrophin signaling. The authors explicitly characterized these findings as preliminary and noted that no human clinical trials in neurological populations had been conducted at the time of publication.

Looking to source this compound? GHK-Cu (100 mg) is available for laboratory research, with documented batch testing. View its Certificate of Analysis (PDF) ↗

Key Published References

1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520
2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PMID: 26236730
3. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343–346. PMID: 3169264
4. Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257–2265. PMID: 11045606
5. Park JR, Lee H, Kim SI, Yang SR. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget. 2016;7(36):58405–58417. PMID: 27517151
6. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. PMID: 22666519
7. Miller DM, DeSilva D, Pickart L, Aust SD. Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin dependent lipid peroxidation. Adv Exp Med Biol. 1990;264:79–84. PMID: 2244543

Product Availability

GHK-Cu (100 mg) is available for qualified research applications through White Market Peptides: GHK-Cu 100 mg: Research Grade.

Featured in these research blends: GLOW blend (GHK-Cu, BPC-157, TB-500) and the KLOW four-peptide blend.